Literature DB >> 7164826

Biliary excretion of chromium in the rat: a role of glutathione.

T Norseth, J Alexander, J Aaseth, S Langård.   

Abstract

The relative amount of chromium excreted in rat bile after injection of Cr-III is much less than after injection of Cr-VI, about 0.1% and from 6-8% during 5 hours respectively, for corresponding dose levels. The liver to bile ratio was 50-100 for Cr-III injection, for Cr-VI the ratio was 2-3. With doses up to 18 mumol Cr/kg, only Cr-III was found in bile even after injection of Cr-VI. Glutathione depletion of the liver with cyclohexene oxide decreased chromium excretion in bile. Such treatment also decreased the reduction of Cr-VI to Cr-III in the liver cell as only Cr-VI was found in bile. A different distribution of Cr-III in the liver dependent on whether derived from Cr-VI or taken up by the liver as such must be assumed. Taking into account the usual low penetration of biological membranes by Cr-III, a possible active transport mechanism or a specific diffusable Cr-III compound must be postulated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7164826     DOI: 10.1111/j.1600-0773.1982.tb01052.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  4 in total

Review 1.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  The carcinogenicity of chromium and its salts.

Authors:  T Norseth
Journal:  Br J Ind Med       Date:  1986-10

3.  Modification of chromium(VI)-induced DNA damage by glutathione and cytochromes P-450 in chicken embryo hepatocytes.

Authors:  D Y Cupo; K E Wetterhahn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

4.  The role of glutathione in the acute nephrotoxicity of sodium dichromate.

Authors:  K J Na; S Y Jeong; C H Lim
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.